Nasdaq News

(RTTNews) - Thursday, Roche (RHHBY) reported new data from the VOYAGER study showing that Vabysmo (faricimab) delivered durable effectiveness and a consistent safety profile in patients with wet age-related macular degeneration (AMD), diabetic macular edema (DME) and macular edem

(RTTNews) - Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) on Thursday announced an expanded global collaboration to develop and commercialise four next-generation, long-acting immunology antibodies targeting type 2 inflammation.

(RTTNews) - Sentiment in European stock markets is expected to remain weak on Thursday amidst a hardening in global bond yields. Ten-year bond yields have increased more than a quarter percent in Germany, France, U.K., as well as Spain. The easing in crude oil prices, the momentu

Key PointsGE Vernova's backlog and orders are growing faster than expected.

(RTTNews) - Paramount Skydance Corp. (PSKY) and Warner Bros. Discovery, Inc. (WBD) announced that their proposed merger is expected to close on October 6, subject to customary closing conditions.

(RTTNews) - Uranium producer Cameco Corp. (CCJ) said the U.S. and South Korea announced a framework under a prior Memorandum of Understanding that anticipates a $120 billion investment by Korea to fund the construction of nuclear reactors using Westinghouse technology and designs

(RTTNews) - The Boeing Company (BA), the aerospace and defense major, Wednesday announced that it has secured an order of eight 777-8 Freighters and two 777 Freighters from the African carrier Ethiopian Airlines to expand its cargo fleet.

(RTTNews) - Fresenius SE & Co. KGaA (FRE.DE), a health care company, on Thursday announced that it has acquired the remaining 45% stake in mAbxience Holding S.L. for up to 750 million euros.

Key PointsAMD closed with a market cap above $1 trillion for the first time on Sept. 21, 2026.

(RTTNews) - Wednesday, Corvus Pharmaceuticals, Inc. (CRVS) reported the initiation of Phase 1b clinical trial of Soquelitinib in patients with moderate to severe Hidradenitis suppurativa, with enrollment underway.

(RTTNews) - Constellation Energy Corporation (CEG), a power producing company, Wednesday announced that it has signed a 20-year agreement with ecommerce giant Amazon (AMZN) that will support continued investment and expansion of the Calvert Cliffs Clean Energy Center.

(RTTNews) - On Thursday, Sanofi (SNY) and Regeneron Pharmaceuticals (REGN) announced the expansion of their global collaboration to develop and commercialize four next-generation, long-acting immunology antibodies targeting type 2 inflammation.

Key PointsSweetgreen slashed its guidance due to the cyclospora outbreak, but that headwind is now gone.

(RTTNews) - Indian shares are turning in a mixed performance Thursday morning as the mood remains cautious due to elevated oil prices and higher U.S. bond yields amid persisting concerns about the situation in the Middle East and rate hike fears, as well as heavy selling by forei

(RTTNews) - Monte Rosa Therapeutics (GLUE) said it will present clinical results today, October 1, 2026 from the GFORCE-1 Phase 1 study of MRT-8102 in subjects with elevated cardiovascular disease (CVD) risk.

Key PointsThe disposition involved 16,672 shares at an execution value of approximately $2.5 million.

Corn futures were under pressure on Wednesday following USDA’s quarterly stocks report with front months down 18 ¼ to 21 ¼ cents and 2027 crop contracts steady to 9 ¼ cents lower. The CmdtyView national average Cash Corn price was down 20 3/4 cents at $4.58. The quarterly Grain Stocks...

(RTTNews) - United Therapeutics Corporation (UTHR) announced that the U.S. District Court for the District of Delaware ruled in its favor in patent litigation involving Liquidia Technologies' Yutrepia an inhaled treprostinil therapy intended for patients with pulmonary hypertensi

The S&P 500 Index ($SPX ) (SPY ) closed down by -0.25% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.23%. December E-mini S&P futures (ESZ26 ) fell -0.25%, and December E-mini...

(RTTNews) - Eli Lilly and Company (LLY) announced detailed results from the Phase 3 ACHIEVE-4 trial showing that Foundayo (orforglipron) demonstrated cardiovascular safety while delivering sustained improvements in blood sugar control, body weight, and other cardiometabolic measu